Skip to content

An observational study of the safety and efficacy of minimally invasive glaucoma surgery (MIGS) for secondary glaucoma following congenital cataract surgery

An observational study of the safety and efficacy of minimally invasive glaucoma surgery (MIGS) for secondary glaucoma following congenital cataract surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055260
Enrollment
Unknown
Registered
2022-01-05
Start date
2022-01-06
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

secondary glaucoma following congenital cataract surgery

Interventions

case series:None

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged <=18 years; 2. Children with secondary glaucoma after congenital cataract surgery who underwent MIGS in our hospital from 2021 to 2023; 3. Children who are diagnosed with congenital cataract in our hospital from 2021 to 2023 and will undergo cataract extraction or cataract extraction combined with intraocular lens implantation; 4. Children who have undergone cataract extraction due to congenital cataract in the past and plan to undergo two-stage intraocular lens implantation in our hospital from 2021 to 2023; 5. The parents of the children voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Failure to return to the hospital on time to complete follow-up and related examinations; 2. Combined with other eye diseases: such as uveitis, congenital iris abnormalities, eye trauma, etc.; 3. Have a history of serious systemic diseases: congenital heart disease, rheumatic immunity, kidney disease and digestive system diseases.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;ocular hypotensive drugs;

Countries

China

Contacts

Public ContactChen Weirong, Zhang Xiulan

Zhongshan Ophthalmic Center, Sun Yat-Sen University

chenwrq@aliyum.com+86 13501518370, +86 13570166308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026